ORBIMED ADVISORS LLC - Insider Non-Derivative Transactions at Enliven Therapeutics, Inc. (ELVN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 23, 2023, ORBIMED ADVISORS LLC's relationship to Enliven Therapeutics, Inc. (ELVN) is Director,TenPercentOwner, and currently has 8,661,225 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ELVN insiders.
Data Source: SEC.
ORBIMED ADVISORS LLC - Insider Non-Derivative Transactions at ELVN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 24, 2023 | Acquisition -- (Common Stock) | 288114 | 0 | 288114 |
| Feb 24, 2023 | Acquisition -- (Common Stock) | 7611458 | 0 | 8661225 |